Cleveland Clinic Investigates Recurrence in Aggressive Variants of Thyroid Cancer
July 30th 2019Shlomo Koyfman, MD, discusses factors that are associated with the risk of recurrence and death in patients with papillary thyroid cancer with hobnail morphology, an aggressive variant that has been associated with poorer outcomes.
Watch
Analysis Demonstrates Correlation Between Presence of ctDNA and Survival in Melanoma
July 26th 2019David Polsky, MD, PhD, discusses the findings from a liquid biopsy analysis of the COMBI-d trial, which is a phase III trial investigating the combination of dabrafenib and trametinib or dabrafenib alone in patients with BRAF V600E/K–mutant melanoma. Investigators found an association between the presence of baseline circulating tumor DNA (ctDNA) and a poor prognosis with the treatment of BRAF inhibitors.
Watch
Sequencing Treatment Options in Mantle Cell Lymphoma
July 26th 2019Simon Rule, MD, PhD, discusses the current treatment approaches for patients with mantle cell lymphoma in both the United Kingdom and the United States. He says treatment strategies are pretty well established on both sides of the Atlantic Ocean.
Watch